Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk
NCT: NCT07067658 · RECRUITING
Brief Summary
This study will evaluate the Heartfelt device, a novel, passive monitoring system that detects early signs of fluid build-up in patients (oedema) with heart failure by measuring changes in foot and lower leg volume through capture of 3D images. The trial will assess whether this device, when added to standard NHS care, improves quality of life and reduces heart failure-related events compared to standard care alone.
Frequently Asked Questions
What is Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk?
Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk is a clinical trial registered under NCT07067658. Current status: RECRUITING.
What is the status of NCT07067658?
The current status of NCT07067658 (Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk) is: RECRUITING.
When did Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk start?
Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk started on 2025-12-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.